Platelet-derived growth factor regulates cytomegalovirus infection-enhanced obliterative bronchiolitis in rat...

Area of Science:

• Transplantation immunology
• Fibroproliferative disorders

Background:

• Cytomegalovirus (CMV) infection is a known risk factor for obliterative bronchiolitis (OB) development post-lung transplantation.
• Rat cytomegalovirus (RCMV) infection accelerates OB in a rat tracheal allograft model by boosting alloimmune responses and smooth muscle cell (SMC) proliferation.

Purpose of the Study:

• To investigate the role of platelet-derived growth factor (PDGF) in RCMV infection-induced acceleration of OB.
• To explore PDGF signaling as a potential therapeutic target for preventing OB.

Main Methods:

• Utilized a rat tracheal allograft model with rat CMV (RCMV) infection.
• Employed immunohistochemistry and in situ hybridization to assess PDGF ligand and receptor expression.
• Administered a selective PDGF receptor tyrosine kinase inhibitor (CGP 53716) to evaluate its effect on OB development.

Main Results:

• RCMV infection significantly increased PDGF ligand and receptor expression in tracheal allografts, particularly in inflammatory and SMC-like cells.
• Selective inhibition of PDGF receptor tyrosine kinase activity with CGP 53716 effectively prevented OB development in RCMV-infected allograft recipients.

Conclusions:

• Platelet-derived growth factor (PDGF) plays a critical role in the pathogenesis of RCMV infection-enhanced obliterative bronchiolitis (OB).
• Targeting PDGF signaling presents a promising novel strategy for preventing fibroproliferative disorders like OB after lung transplantation.